Investigating the domestic drug registration and declaration, in order to understand the domestic R&D status is an essential item in the drug project investigation, there are many ways to inquire about these domestic drug registration and declaration online, such as inquiring in the official "CDE" drug evaluation center and inquiring about the domestic drug registration and declaration in major databases. It is suggested to use the database to inquire about the domestic drug registration and declaration.

"China Drug Evaluation" database is the key and characteristic database in drug research and development, and it is also a professional information query system for drug registration and declaration in China.

1, authoritative data source.

The data of National Medical Supplies Administration (NMPA) and Drug Evaluation Center (CDE) are integrated, but not only data processing, but also data refining, and a set of standard operating procedures are formulated, which can not only obtain data conveniently and quickly, but also understand the real situation reflected by the data.

For example, in the search results page, there are small signs such as "new" and "knowledge", which can quickly know whether it is "declaration of newly registered generic drugs" or "conformity evaluation".

Drug registration declaration

2. Retrieve multiple styles

1.？ Basic search: fuzzy search and accurate search through keywords to quickly query the registration acceptance information of a drug.

2.？ Hot spot search: provide a one-stop search mode through the recent hot drugs and data searched by users.

3.？ Conditions screening: Conditions can be screened by ATC code, priority review, major projects, special review, breakthrough treatment, consistency evaluation, drug type, application type of acceptance number, application type, registration type, treatment status, review conclusion, consistency evaluation, implied permission of clinical trials, direct administrative approval, review report and instructions.

4.？ Advanced filtering combines the logic of "AND", "OR" and "No" through various conditions, which has a high degree of custom attributes and meets the requirements of personalized retrieval.

For example, if you enter the keyword "lung cancer" in the reference indication and select "new drug" in the application type of conditional screening, you can quickly query the registration and declaration of new drugs with "lung cancer" indications in China.

Registration statement

3, intelligent update data

Rolling and updating official website data all day can ensure the timeliness of data.

Registration and declaration data

4. The conclusion of the review is clear.

The review conclusion in the review summary of the details page is clear, including the specific review conclusion information of drugs.

The review report is clear.

5. Review the timeline

1. Displays the complete time progress from drug declaration to drug approval;

2. Contains statistical information of each major review status;

3. Intuitively present the review progress of the target product.

Timeline of registration declaration

6. Intelligent visual analysis

Using visual charts can intuitively understand the competition pattern and grasp the trend of new drug research and development in China.

Registration and declaration

It is recommended to use the database to inquire about the registration and declaration of domestic drugs, which is convenient for enterprises to inquire about the declaration progress and queuing situation of varieties under research, and is helpful to track the progress of domestic new drug research and development in real time, understand the competition pattern of domestic new drug research and development, and grasp the trend of domestic new drug research and development.